Related Experiment Video
Updated: Jan 11, 2026

Visualizing Mitophagy with Fluorescent Dyes for Mitochondria and Lysosome
Published on: November 30, 2022
Mitochondrial NAD+-mediated mitophagy alleviates type I interferon response to the cytosolic mitochondrial DNA
Tian Lan1, Dantong Shang1, Lan Lin1
1Hubei Key Laboratory of Cell Homeostasis, College of Life Sciences, Renmin Hospital of Wuhan University, Wuhan University, Wuhan, China.
Abstract:
Mitochondrial nicotinamide adenine dinucleotide (NAD+) plays a central role in energy metabolism, yet its roles and mechanisms in mitophagy and innate immunity remain poorly understood. In this study, we identify mitochondrial NAD+ depletion that causes mitophagy dysfunction and inflammation. We find that depletion of mitochondrial NAD+ owing to deficiency of the mitochondrial NAD+ transporter SLC25A51 impairs BNIP3-mediated mitophagy. Loss of mitochondrial NAD+ inhibits SIRT3-mediated deacetylation of FOXO3, leading to transcriptional downregulation of BNIP3 and subsequent disruption of MAP1LC3B/LC3B recruitment. Notably, mitochondrial NAD+ depletion promotes mitochondrial DNA (mtDNA) release from mitochondria to the cytosol upon oxidative stress, thereby exacerbating the type I interferon response to free cytosolic mtDNA via activation of the CGAS-STING1 signaling pathway. Our findings reveal a novel mechanistic link among mitochondrial NAD+, mitophagy, and mtDNA-induced inflammation by genetic manipulation of cell lines, highlighting mitochondrial NAD+ as a potential therapeutic target for mitigating sterile inflammation triggered by free cytosolic mtDNA. Thus, the study provides new insights into the crosstalk among mitochondrial homeostasis, inflammation, and innate immunity.Abbreviations: Baf A1: bafilomycin A1; BNIP3: BCL2 interacting protein 3; CCCP: carbonyl cyanide m-chlorophenyl-hydrazone; CCL5: C-C motif chemokine ligand 5; CGAS: cyclic GMP-AMP synthase; COX4/COX-IV: cytochrome c oxidase subunit 4; CXCL10: C-X-C motif chemokine ligand 10; D-LOOP: displacement loop; EBSS: Earle's balanced salt solution; ELISA: enzyme-linked immunosorbent assay; FIS1: fission, mitochondrial 1; FOXO3: forkhead box O3; IFN: interferon; IFNB/IFNβ: interferon beta; IRF3: interferon regulatory factor 3; KO: knockout; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; mtDNA: mitochondrial DNA; NAD: nicotinamide adenine dinucleotide; MT-ND1: mitochondrially encoded NADH dehydrogenase 1; RT-PCR: real-time polymerase chain reaction; SIRT3: sirtuin 3; SLC25A51: solute carrier family 25 member 51; SoNar: sensor of NAD+ and NADH redox; SQSTM1: sequestosome 1; STING1: stimulator of interferon response cGAMP interactor 1; TBK1: TANK binding kinase 1; TOMM20: translocase of outer mitochondrial membrane 20; VDAC2: voltage dependent anion channel 2.
Insights
Mitochondrial NAD+ depletion impairs mitophagy and promotes inflammation by releasing mtDNA, highlighting NAD+ as a therapeutic target for sterile inflammation.
Area of Science:
- Cellular Biology
- Immunology
- Metabolism
Background:
- Mitochondrial nicotinamide adenine dinucleotide (NAD+) is crucial for energy metabolism.
- Its roles in mitophagy and innate immunity are not well understood.
- Dysfunctional mitophagy and inflammation are linked to various diseases.
Purpose of the Study:
- To investigate the role of mitochondrial NAD+ in mitophagy and innate immunity.
- To elucidate the mechanisms by which mitochondrial NAD+ affects these processes.
- To identify potential therapeutic targets for sterile inflammation.
Main Methods:
- Genetic manipulation of cell lines, including knockout (KO) models.
- Assessment of mitophagy using techniques like MAP1LC3B/LC3B recruitment.
- Analysis of mitochondrial DNA (mtDNA) release and type I interferon response.
- Measurement of NAD+ levels using sensors like SoNar.
Main Results:
- Mitochondrial NAD+ depletion, caused by SLC25A51 deficiency, impairs BNIP3-mediated mitophagy.
- Loss of mitochondrial NAD+ inhibits SIRT3-mediated FOXO3 deacetylation, downregulating BNIP3.
- Depleted mitochondrial NAD+ promotes mtDNA release and exacerbates type I interferon response via CGAS-STING1 signaling.
Conclusions:
- Mitochondrial NAD+ depletion disrupts mitophagy and triggers inflammation.
- A mechanistic link exists between mitochondrial NAD+, mitophagy, and mtDNA-induced inflammation.
- Mitochondrial NAD+ is a potential therapeutic target for sterile inflammation caused by free mtDNA.
Related Concept Videos
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Animal Mitochondrial Genetics
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
The Inner Mitochondrial Membrane
Mitochondrial Membranes

